UNIV OF MISSOURI HEALTH CARE
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $187.3M
- Transactions
- 5,088
- Companies
- 40
- Average per transaction
- $36,818
Who reported the payments
| Advanced Accelerator Applications | $157,770,931 |
| Synthes USA Products LLC | $3,621,752 |
| Lantheus Medical Imaging, Inc. | $2,920,565 |
| Modernatx, Inc. | $1,653,450 |
| Merck | $1,164,349 |
| AstraZeneca | $968,432 |
| Jazz Pharmaceuticals Inc. | $937,134 |
| Roche Molecular Systems, Inc. | $914,659 |
| GE HealthCare | $796,967 |
| Arthrex | $786,695 |
| Siemens Medical Solutions USA, Inc. | $699,000 |
| Medtronic | $668,416 |
| Biomarin Pharmaceutical Inc. | $652,813 |
| Olympus Corporation Of The Americas | $564,874 |
| Musculoskeletal Transplant Foundation Inc. | $553,161 |
| Regeneron | $539,841 |
| Tesaro, Inc. | $480,130 |
| Vertex | $448,374 |
| Pfizer | $447,692 |
| Eli Lilly | $397,716 |
| Boehringer Ingelheim | $393,002 |
| Medical Device Business Services, Inc. | $369,462 |
| Gilead | $352,950 |
| AbbVie | $336,796 |
| Elite Orthopedics, LLC | $324,882 |
| Merz Pharmaceuticals, LLC | $291,894 |
| Takeda Pharmaceuticals U.S.A., Inc. | $266,738 |
| Janssen Research & Development, LLC | $263,972 |
| Genentech, Inc. | $253,565 |
| Cognoa, Inc. | $250,000 |
| Guerbet LLC | $249,990 |
| Baxter Healthcare | $244,361 |
| Ortho-clinical Diagnostics, Inc. | $242,467 |
| CSL Behring | $225,847 |
| Amgen | $199,355 |
| Ethicon Endo-surgery Inc. | $194,058 |
| Ipsen Pharma SAS | $193,413 |
| Optinose US, Inc. | $189,958 |
| Zimmer Biomet | $185,587 |
| Novartis | $184,771 |